- Home
- Publications
- Publication Search
- Publication Details
Title
Adaptive designs for dual-agent phase I dose-escalation studies
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 10, Issue 5, Pages 277-288
Publisher
Springer Nature
Online
2013-03-19
DOI
10.1038/nrclinonc.2013.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- General classes of multiple binary regression models in dose finding problems for combination therapies
- (2013) Mauro Gasparini JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Safety and feasibility of targeted agent combinations in solid tumours
- (2013) Sook Ryun Park et al. Nature Reviews Clinical Oncology
- The Impact of Non-Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials
- (2012) A. Iasonos et al. CLINICAL CANCER RESEARCH
- A Two-Dimensional Search Algorithm for Dose-Finding Trials of Two Agents
- (2012) Bee Leng Lee et al. Journal of Biopharmaceutical Statistics
- The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research
- (2012) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Escalation strategies for combination therapy Phase I trials
- (2012) Michael J. Sweeting et al. PHARMACEUTICAL STATISTICS
- A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer
- (2012) John Whitehead et al. STATISTICS IN MEDICINE
- Interplay of priors and skeletons in two-stage continual reassessment method
- (2012) Alexia Iasonos et al. STATISTICS IN MEDICINE
- Bayesian phase I/II adaptively randomized oncology trials with combined drugs
- (2011) Ying Yuan et al. Annals of Applied Statistics
- Toxicity burden score: a novel approach to summarize multiple toxic effects
- (2011) S. M. Lee et al. ANNALS OF ONCOLOGY
- Continual Reassessment Method for Partial Ordering
- (2011) Nolan A. Wages et al. BIOMETRICS
- Beyond the 3+3 method: expanded algorithms for dose- escalation in Phase I oncology trials of two agents
- (2011) Thomas M Braun et al. Clinical Trials
- Dose-finding design for multi-drug combinations
- (2011) Nolan A Wages et al. Clinical Trials
- Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design
- (2011) Amye Tevaarwerk et al. INVESTIGATIONAL NEW DRUGS
- Adaptive clinical trials in oncology
- (2011) Donald A. Berry Nature Reviews Clinical Oncology
- Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinations
- (2011) John Whitehead et al. STATISTICS IN MEDICINE
- Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading
- (2011) Emily M. Van Meter et al. STATISTICS IN MEDICINE
- A Bayesian response-adaptive covariate-balanced randomization design with application to a leukemia clinical trial
- (2011) Ying Yuan et al. STATISTICS IN MEDICINE
- Bayesian adaptive clinical trials: a dream for statisticians only?
- (2011) Sylvie Chevret STATISTICS IN MEDICINE
- Continual reassessment method with multiple toxicity constraints
- (2010) S. M. Lee et al. BIOSTATISTICS
- An Overview of the Optimal Planning, Design, and Conduct of Phase I Studies of New Therapeutics
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) S. P. Ivy et al. CLINICAL CANCER RESEARCH
- A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials
- (2010) Arzu Onar-Thomas et al. Contemporary Clinical Trials
- Bayesian dose finding in oncology for drug combinations by copula regression
- (2010) Mauro Gasparini et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- Combining Targeted Therapies: Practical Issues to Consider at the Bench and Bedside
- (2010) J. Rodon et al. ONCOLOGIST
- Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials
- (2010) Peter F. Thall STATISTICAL SCIENCE
- Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges
- (2010) Sumithra J. Mandrekar et al. STATISTICS IN MEDICINE
- A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents
- (2009) Thomas M. Braun et al. BIOMETRICS
- Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
- (2009) Nadine Houede et al. BIOMETRICS
- Bayesian clinical trials: no more excuses
- (2009) Mithat Gönen Clinical Trials
- Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center
- (2009) Swati Biswas et al. Clinical Trials
- A two-stage algorithm for designing phase I cancer clinical trials for two new molecular entities
- (2009) Zheng Su Contemporary Clinical Trials
- Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium
- (2009) Arzu Onar et al. Journal of Biopharmaceutical Statistics
- A Bayesian Case Study in Oncology Phase I Combination Dose-Finding Using Logistic Regression with Covariates
- (2009) Stuart Bailey et al. Journal of Biopharmaceutical Statistics
- Phase I Drug Combination Trial Design: Walking the Tightrope
- (2009) Paul Hamberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Bayesian dose finding in oncology for drug combinations by copula regression
- (2009) Guosheng Yin et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents
- (2008) Guosheng Yin et al. BIOMETRICS
- Optimal modeling for phase I design of a two drug combination—results of a phase I study of cisplatin with 9-nitrocamptothecin
- (2008) S.-J. Lee et al. INVESTIGATIONAL NEW DRUGS
- Critical aspects of the Bayesian approach to phase I cancer trials
- (2008) Beat Neuenschwander et al. STATISTICS IN MEDICINE
- Adaptive designs for selecting drug combinations based on efficacy–toxicity response
- (2007) Vladimir Dragalin et al. JOURNAL OF STATISTICAL PLANNING AND INFERENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started